In vitro IgE production by interleukin 4-stimulated human peripheral blood mononuclear cells is suppressed by rapamycin
- 31 December 1991
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 61 (3) , 410-420
- https://doi.org/10.1016/s0090-1229(05)80012-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Suppression of B cell activation by cyclosporin A, FK506 and rapamycinEuropean Journal of Immunology, 1990
- Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon‐γEuropean Journal of Immunology, 1990
- Recombinant interleukin (IL) 2‐induced human B cell differentiation is mediated by autocrine IL6European Journal of Immunology, 1989
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTINGThe Lancet, 1989
- Human IgE-binding factorsImmunology Today, 1989
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens.The Journal of Experimental Medicine, 1989
- Molecular Cloning and Expression of a Human B-Cell Growth Factor Gene in Escherichia coliScience, 1987